See All Slides - tctmd.com

Slides

Presentation TCT 2019

TCT 13: Alirocumab improve coronary plaque vulnerability: first randomized control trial to assess the effect of alirocumab for plaque vulnerabilityusing optical coherence tomography.

Presenter: yoichiro sugizaki

September 25, 2019

Presentation TCT 2019

TCT 45: Safety and Performance of the Resorbable Magnesium Scaffold, Magmaris in a Real World Setting - First Cohort Subjects at 12-month Follow-up of the BIOSOLVE-IV Registry

Presenter: Stefan Verheye

September 25, 2019

Presentation TCT 2019

TCT 53: Impact of Intravascular Ultrasound Utilization on Outcomes Following Percutaneous Coronary Intervention for In-stent Restenosis

Presenter: Evan Shlofmitz

September 25, 2019

Presentation TCT 2019

TCT 21: Incidence And Clinical Outcomes Of Stroke In Patients With Percutaneous Mechanical Circulatory Support Devices: Insights from Large National Database

Presenter: Mohit Pahuja

September 25, 2019

Presentation TCT 2019

TCT 29: Impact of intravascular ultrasound-guided drug-eluting stent implantation on patients with chronic kidney disease: subgroup analysis from ULTIMATE trial

Presenter: Junjie Zhang

September 25, 2019

Presentation TCT 2019

TCT 61: One-Year Outcome of Subintimal versus Intraluminal Approach, Subintimal versus Intraluminal Wire Passage Based on Intravascular Ultrasound Findings For Femoro-Popliteal Chronic Total Occlusions.

Presenter: Yusuke Tomoi

September 25, 2019

Presentation TCT 2019

Cath Lab Honorees

Presenter: Judy Tingley

September 25, 2019

Presentation TCT 2019

Market Analysis

Presenter: Lucy Schlueter

September 25, 2019

Presentation TCT 2019

Distal Embolic Protections Are Expensive and Have Inherent Risks: When Are They Absolutely Necessary?

Presenter: Peter Schneider

September 25, 2019

Presentation TCT 2019

Who, When, How: A Primer of ASD Closure in Adults

Presenter: William Gray

September 25, 2019

Advertisement

Slides

TCT 13: Alirocumab improve coronary plaque vulnerability: first randomized control trial to assess the effect of alirocumab for plaque vulnerabilityusing optical coherence tomography.

TCT 45: Safety and Performance of the Resorbable Magnesium Scaffold, Magmaris in a Real World Setting - First Cohort Subjects at 12-month Follow-up of the BIOSOLVE-IV Registry

TCT 53: Impact of Intravascular Ultrasound Utilization on Outcomes Following Percutaneous Coronary Intervention for In-stent Restenosis

TCT 21: Incidence And Clinical Outcomes Of Stroke In Patients With Percutaneous Mechanical Circulatory Support Devices: Insights from Large National Database

TCT 29: Impact of intravascular ultrasound-guided drug-eluting stent implantation on patients with chronic kidney disease: subgroup analysis from ULTIMATE trial

TCT 61: One-Year Outcome of Subintimal versus Intraluminal Approach, Subintimal versus Intraluminal Wire Passage Based on Intravascular Ultrasound Findings For Femoro-Popliteal Chronic Total Occlusions.

Cath Lab Honorees

Market Analysis

Distal Embolic Protections Are Expensive and Have Inherent Risks: When Are They Absolutely Necessary?

Who, When, How: A Primer of ASD Closure in Adults

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content